Politics
BioNTech Founders Transition to New Venture
Ugur Sahin and Özlem Türeci, key figures in the development of the first Western COVID-19 vaccine, are stepping down to pursue new opportunities.
Editorial Staff
1 min read
Ugur Sahin and Özlem Türeci, the founders of BioNTech, have announced their decision to step down from their current roles to initiate a new venture.
Their previous work was pivotal in the rapid development and approval of the first COVID-19 vaccine in Western markets, setting a precedent in mRNA technology.
As they embark on this new journey, they express readiness to explore innovative pathways and contribute to advancements in the biopharmaceutical landscape.